Results for tag: "Brucellosis Vaccines"

The Brucellosis Vaccines market is a specialized segment within the veterinary and zoonotic disease diagnostics, prevention, and containment industry. Brucellosis is a contagious disease caused by the Brucella bacteria, which affects various animals, including cattle, sheep, goats, and pigs, and has zoonotic potential. Diagnosing brucellosis is critical in controlling its spread and mitigating the economic impact on livestock production. The vaccines are designed to immunize susceptible animals, thereby reducing the incidence of the disease. Diagnostic tests and protocols are implemented alongside vaccination programs to monitor the effectiveness of the vaccines and to certify herds as brucellosis-free. These diagnostics include serological tests, such as ELISA (enzyme-linked immunosorbent assay) and PCR (polymerase chain reaction) that detect antibodies or DNA of the causative organism. Together, diagnostics and vaccines play a complementary role in comprehensive brucellosis control programs aimed at eradicating the disease. Companies that are participants in the brucellosis vaccine market typically include veterinary pharmaceutical and biotechnology firms. Key players may also engage in the production of diagnostic assays and reagents. Notable companies in this market include Zoetis, Merck Animal Health, Ceva Sante Animale, and Indian Immunologicals Limited. These firms invest in research and development to improve vaccine efficacy and to support diagnostic advancements, collaborating with government agencies and animal health organizations to tackle br Show Less Read more